CCMT
MRNA icon

CMT Capital Markets Trading’s Moderna MRNA Stock Holding History

CMT Capital Markets Trading’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-7,721
Closed -$203K – 326
2025
Q1 		$219K Sell
7,721
-12,011
-61% -$426K ﹤0.01% 287
2024
Q4 		$820K Buy
19,732
+8,358
+73% +$399K 0.01% 255
2024
Q3 		$760K Sell
11,374
-3,791
-25% -$348K 0.01% 245
2024
Q2 		$1.8M Buy
+15,165
New +$1.92M 0.02% 216
2023
Q3 		– Sell
-8,471
Closed -$945K – 253
2023
Q2 		$1.03M Buy
+8,471
New +$1.13M 0.01% 210
2023
Q1 		– Sell
-8,214
Closed -$1.36M – 277
2022
Q4 		$1.48M Buy
8,214
+2,850
+53% +$466K 0.01% 235
2022
Q3 		$634K Buy
+5,364
New +$814K ﹤0.01% 280

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

CMT Capital Markets Trading's MRNA Position: Q2 2025 in Review

CMT Capital Markets Trading sold out of Moderna (MRNA) in Q2 2025, closing a stake of 7,721 shares — an estimated $203K sold.

CMT Capital Markets Trading first reported a position in MRNA in Q3 2022 and held it in 7 quarters. The position peaked at $1.8M in Q2 2024. 674 funds tracked by Wall St. Rank hold MRNA as of Q2 2025.

  • CMT Capital Markets Trading reported no remaining Moderna position as of Q2 2025 after selling out during the quarter.
  • CMT Capital Markets Trading sold 7,721 Moderna shares in Q2 2025, an estimated $203K.
  • CMT Capital Markets Trading first reported a position in Moderna in Q3 2022 and held it in 7 quarters.
  • CMT Capital Markets Trading's Moderna position peaked at $1.8M in Q2 2024.
  • 674 funds tracked by Wall St. Rank held Moderna as of Q2 2025.

Based on CMT Capital Markets Trading's 13F filing for Q2 2025, filed 13 Aug 2025.